Replies to post #139696 on Biotech Values

[goochbart]

Biomaven,

Have you given up on Exel?

Carbo, I believe has nine presentations scheduled.

[gfp927z]

Biomaven, Thanks. Any thoughts on ARRY?

They'll have fuller data for Selumetinib at ASCO, but with their large pipeline and vast number of partnered programs, (and still small market cap), do you see Array emerging as a core holding?

[jq1234]

ARQL is going to present ARQ197 in HCC data.

EXEL is going to present XL184 in MTC, RCC, and more mature CRPC data. Like to see duration of response in CRPC.